SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY MALE VOLUNTEERS.

被引：0
|
作者：
Koenen, R. [1 ]
Fowler, A. [2 ]
Gupta, A. [1 ]
Hilbert, J. [3 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[2] Boehringer Ingelheim Ltd, Bracknell, Berks, England
[3] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-011
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [41] PHARMACODYNAMICS AND PHARMACOKINETICS OF RACLOPRIDE AFTER SINGLE ORAL DOSES IN MALE-VOLUNTEERS
    WAHLEN, A
    FARDE, L
    VONBAHR, C
    SEDVALL, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 178 - 178
  • [42] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects
    Sakurai, Yuuichi
    Nishimura, Akira
    Kennedy, Gale
    Hibberd, Mark
    Jenkins, Richard
    Okamoto, Hiroyuki
    Yoneyama, Tomoki
    Jenkins, Helen
    Ashida, Kiyoshi
    Irie, Shin
    Taeubel, Joerg
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2015, 6
  • [43] A PHASE I ADAPTIVE DESIGN STUDY TO ASSESS SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING ORAL DOSES OF GIC-1001 IN HEALTHY VOLUNTEERS.
    Sayegh, L.
    Rufiange, M.
    Sadoune, A. Ait
    Sicard, E.
    Massicotte, J.
    Lefebvre, M.
    Colin, P.
    Ranger, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S63 - S64
  • [44] EFFECT OF MULTIPLE-DOSE SETIPIPRANT, A SELECTIVE ORAL CRTH2 ANTAGONIST, ON THE PHARMACOKINETICS OF SINGLE-DOSE SIMVASTATIN IN HEALTHY MALE SUBJECTS
    Gehin, M.
    Mackie, A.
    Sidharta, P. N.
    Kadlecova, P.
    Petersen-Sylla, M.
    Halabi, A.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S42 - S42
  • [45] SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF FALDAPREVIR AFTER SINGLE RISING DOSES IN HEALTHY SUBJECTS
    Sennewald, R.
    Narjes, H.
    Yong, C.
    Nehmiz, G.
    Huang, F.
    Stern, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S69 - S69
  • [46] Safety, tolerability, pharmacokinetic profile and pharmacodynamic characteristics of sabiporide, a novel cardioselective NHE-inhibitor, after oral and IV single doses in healthy male volunteers.
    Klueglich, M
    Rathgen, K
    Nehmiz, G
    Trommeshauser, D
    Seidler, R
    Rathgen, K
    Nehmiz, G
    Trommeshauser, D
    Seidler, R
    Roberts, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1056 - 1056
  • [47] Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral AL01211 in Healthy Chinese Volunteers
    Dong, Lei
    Xiang, Jianxing
    Babcock, Michael
    Cheng, Yuanzhi
    Wang, Yan
    Shen, Yuqiao
    Li, Li
    Tan, Liping
    Garovoy, Marvin
    Hu, Wei
    Zheng, Jianhong
    CLINICAL DRUG INVESTIGATION, 2024, 44 (06) : 387 - 398
  • [48] Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects
    Yamahira, Naomi
    Frost, Charles
    Fukase, Hiroyuki
    Yu, Zhigang
    Wang, Jessie
    Pursley, Janice
    LaCreta, Frank
    Hiraoka, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (07) : 564 - 573
  • [49] Asenapine Safety, Tolerability, and Pharmacokinetics After Single and Multiple Doses in Healthy Volunteers
    Dogterom, Peter
    Timmer, Cees
    de Greef, Rik
    Spaans, Edwin
    de Vries, Dick
    van Vliet, Andre
    Peeters, Pierre
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (04): : 131 - 143
  • [50] TRANDOLAPRIL - PHARMACOKINETICS OF SINGLE ORAL DOSES IN HEALTHY MALE-VOLUNTEERS
    LENFANT, B
    MOUREN, M
    BRYCE, T
    DELAUTURE, D
    STRAUCH, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 : S38 - S43
12345